Project Grant R01HD118713
- The Department of Health and Human Services National Institutes of Health (NIH) awarded a $250,000 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Fred Hutchinson Cancer Center, also known as the Seattle Cancer Care Alliance, to conduct a hybrid effectiveness-implementation cluster-randomized controlled trial across 20 pharmacies in Kenya. The goal of the project is to leverage telehealth to optimize the delivery of pre-exposure prophylaxis (PrEP) and...
- This federal Project Grant award of $234,292 from the National Institutes of Health's Fogarty International Center (CFDA 93.989 - International Research and Research Training) aims to develop and pilot test a multilevel, community-based intervention to reduce pre-exposure prophylaxis (PrEP) stigma and increase PrEP uptake and continuation among adolescent girls and young women (AGYW) ages 15-24 in Western Kenya. The key products and services to be delivered under this 3-year award include: 1)...
- This $747,000 Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will fund research to determine the effects of pre-exposure prophylactic (PrEP) drugs on female genital HIV infection and women's reproductive health. The research will focus on understanding how PrEP impacts the female reproductive tract microenvironment and any potential...
- The University of South Florida (USF) received a $389,527 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) to conduct a study examining strategies and contextual factors that optimize the delivery of pre-exposure prophylaxis (PrEP) for HIV prevention in Kenya. The key products and services to be delivered through this two-year project include: Identifying implementation strategies and contextual factors that...
- This Project Grant award from the Department of Health and Human Services' Fogarty International Center (CFDA 93.989 - International Research and Research Training) provides $621,999 to The University of Iowa to adapt and pilot test a multi-level, peer-led HIV prevention and stigma reduction intervention for adolescents in Western Kenya. The project aims to reduce HIV and sexual and reproductive health-related stigma, and increase HIV preventive behaviors among youth in the region. Key...
- This Project Grant award of $665,225 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to improve access and adherence to Pre-Exposure Prophylaxis (PrEP) among adolescent girls and young women in Uganda. The 5-year project, titled "SUUBI4PREP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda", will combine peer support interventions with economic empowerment initiatives to address...
- This federal Project Grant award for $657,907 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support a 5-year longitudinal analysis to understand the impact of expanding pharmacists' scope of practice on the uptake and retention of pre-exposure prophylaxis (PrEP) for HIV prevention. The project aims to integrate multiple data sources, including policy, census, survey, and medical claims data, to...
- This Project Grant award from the National Institute of Nursing Research (NINR) under the Nursing Research federal grant program (CFDA 93.361) supports research to investigate the mechanisms of action for a mobile SMS-based pre-exposure prophylaxis (PrEP) adherence intervention in Kenya. The $205,948 award to the University of Washington will be used to analyze data from the parent MWACH PrEP study, which is testing the impact of an interactive SMS platform on PrEP adherence and maintenance...
- This $731,738 Project Grant awarded by the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) will fund a pilot feasibility study to integrate pre-exposure prophylaxis (PrEP) into emergency department and urgent care settings using a patient-centered decision support tool. The goal is to improve PrEP awareness, access, and uptake among groups at highest risk for acquiring HIV, such as men who have sex with men, young people, racial/ethnic minorities, and women of...
- This Project Grant award of $962,973.00 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to develop and evaluate a comprehensive curriculum on HIV prevention and implementation science for pharmacy schools in the southern United States. The project, titled "Pharmacists for Prevention (P4P): Harnessing the Role of Pharmacists in Ending the HIV Epidemic through Collaboration with Pharmacy Schools," will be...
The University of Washington was awarded a $985,308 Project Grant from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) to advance pharmacy-based delivery of primary sexually transmitted infection (STI) and HIV prevention for cisgender women in Kenya. The funding supports research to evaluate strategies for addressing STIs and promoting HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) uptake among adolescent girls and young women through pharmacies, where many access contraception without facility-based care. Key objectives include assessing the feasibility and impact of providing STI testing, expedited partner therapy, and event-driven HIV PEP in pharmacy settings. The project aims to develop evidence-based approaches for expanding access to critical STI and HIV prevention services for this high-risk population in East Africa.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $191.8k | 9/8/25 | ||
| Not listed | $793.5k | 9/5/25 |